Company Spotlight

SGS Health Science

75 Passaic Avenue
Fairfield, NJ 07004
United States
View Profile

Contract Service Directory


Company Headquarters

125 Sandy Drive
Newark, DE 19713
United States

Contract Service Directory

    Related Content

    • Bio News | Biosimilars
      Know the Challenges of Biosimilar Manufacturing

      Know the Challenges of Biosimilar Manufacturing

      Best Practices for a Competitive Market
      Jerry Martin, Pharmaceutical and Life Sciences Consultant to PMMI, and, Dr. Michiel Ultee, Principal, Ulteemit BioConsulting, LLC 04.11.18

    • Bio News | Biologics, Proteins, Vaccines | cGMP Manufacture | Industry News
      NIBRT, GE Healthcare Open SU Bio-Mfg. CoE

      NIBRT, GE Healthcare Open SU Bio-Mfg. CoE

      Aims to drive next-generation biomanufacturing expertise with a new training center

    • Breaking News | Drug Delivery | Industry News | Inspections
      Tapemark Passes Regulatory Hurdle

      Tapemark Passes Regulatory Hurdle

      Manufacturing facility completes successful FDA pre-approval and general GMP inspection

    • Inspections | Regulatory Affairs

      Warning Letters & Close-out Letters

      Why does it take so long to get a close-out letter?

    • Breaking News | Industry News | Inspections
      BioPharma Services Completes 3 FDA Inspections

      BioPharma Services Completes 3 FDA Inspections

      No Form 483’s reported

    • Breaking News | Facilities | Industry News | Inspections
      Frontida BioPharm Launches Expansion Efforts

      Frontida BioPharm Launches Expansion Efforts

      Comes on heels of receiving FDA clearance

    • Regulatory Affairs
      The FDA and Metrics

      The FDA and Metrics

      The Agency and industry continue to work together to achieve FDA’s objectives
      David Lonza, Lachman Consultant Services, Inc. 05.09.17

    • Breaking News | Clinical Trial Materials | Clinical Trials | Drug Development | Facilities | Industry News
      Carmell Therapeutics Expands Mfg. Capabilities

      Carmell Therapeutics Expands Mfg. Capabilities

      Will soon enter a Phase III study for its bone healing accelerant product

    • Regulatory Affairs

      Establishments, Identifications, Submissions and Beyond

      A closer look at electronic submissions of manufacturing establishment information (MEI).
      Sharif Ahmed, Lachman Consultants 04.03.17

    • Trump Picks New FDA Commish

      Combatting high drug prices and overregulation likely to be high on agenda
      Tim Wright, Editor 04.03.17

    • Bio News | Breaking News | Facilities | Fill/Finish | Industry News | Injectables | Parenterals

      Aptar Pharma Inaugurates Congers Site Expansion

      Facility will be used for injectable elastomeric component manufacturing

    • Capsules | Solid Dosage/Semi-solids

      Generic Drug Trends

      Industry faces tighter capacity, consolidation, and drug pricing uncertainty
      Edward S. Price, President, PCI 03.07.17

    • Regulatory Affairs

      Whither Washington?

      With a new administration, the future of the FDA may be the biggest wildcard in the outlook for CDMOs and their customers
      Gil Roth, President, Pharma & Biopharma Outsourcing Association 03.07.17

    • Regulatory Affairs

      Challenges and Advantages of International Regulatory Inspections

      A look at the processes and approaches followed by FDA
      Daniel Barreto, Lachman Consultants 03.07.17

    • Aseptic Processing | Bio News | Breaking News | Facilities | Fill/Finish | Industry News | Inspections | Lyophilization

      LSNE Completes Two FDA Inspections

      FDA PAI and general GMP inspection of two aseptic manufacturing plants and QC laboratory completed successfully

    • Drug Development | Drug Discovery | Industry News

      BMS, GRAIL in Precision Medicine Pact

      BMS investment aims to advance pipeline with highly sensitive blood tests that detect cancer early

    • QA/QC | Regulatory Affairs
      FDA’s Quality Agreements Guidance

      FDA’s Quality Agreements Guidance

      Evaluation of FDA’s recently issued Contract Manufacturing Arrangements for Drugs: Quality Agreements Guidance for Industry
      Paul Mason, Ph.D., Director of Lachman Consultant Services, Inc. 01.26.17

    • Biologics, Proteins, Vaccines | Drug Discovery | Industry News

      Eurofins Genomics Expands Express Oligo Service

      Express Oligo service aims to allow more customers to receive primers in a shorter turnaround time